UNSPSC 85641647: Change other device in lower extremity subcutaneous tissue and fascia, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to change other device in lower extremity subcutaneous tissue and fascia, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0J2WXYZ

UNSPSC 85641647 Change other device in lower extremity subcutaneous tissue and fascia, external approach is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The code's nominal scope describes a specific surgical procedure for managing implanted lower-extremity devices, yet the recent opportunities posted under this code involve healthcare service contracting—inmate medical and pharmacy services, pharmacy benefit management, virtual primary and urgent care, peer support services, and fire department medical direction—none of which match the code's clinical procedure definition. State and local procurement systems occasionally misapply UNSPSC codes to opportunities where the taxonomy does not fit the actual work being bought, and this code appears to be a mismatch of that kind. No opportunities in the recent posting block represent the procurement of surgical intervention, medical devices for subcutaneous implantation, or related clinical supplies or equipment for lower extremity procedures.

Because the posted opportunities do not reflect genuine demand for goods or services under the code's actual scope, this code shows no actionable activity for a business development professional pursuing state and local contracts for change devices in lower extremity subcutaneous tissue. If your firm supplies such devices or related surgical materials to state prison systems, county health departments, or other public health agencies, monitor the code for future postings—but do not rely on the current batch of healthcare service RFPs as evidence of buying interest in this specific product line.